Gensight Biologics SA banner

Gensight Biologics SA
PAR:SIGHT

Watchlist Manager
Gensight Biologics SA Logo
Gensight Biologics SA
PAR:SIGHT
Watchlist
Price: 0.1204 EUR -2.9% Market Closed
Market Cap: €28.3m

Intrinsic Value

The intrinsic value for Gensight Biologics SA (SIGHT) under the Base Case is 0.1998 EUR. Compared with the current market price of 0.1204 EUR, the stock appears Undervalued by 40% .

Intrinsic value calculated using Multiples
€0.1998
Other reference points

Do our valuations actually work? See backtest results .

SIGHT Intrinsic Value
0.1998
Undervaluation 40%
Intrinsic Value
Price €0.1204
Monitor SIGHT
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €0.16
Get notified when the price drops into your buy zone
Intrinsic Value €0.2
Margin of Safety 20% €0.16
Current Price €0.12
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Ask AI Assistant
What other research platforms think about SIGHT?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is SIGHT valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Gensight Biologics SA.

Explain Valuation
Alternatives to SIGHT

Fundamental Analysis

Financials
Efficiency

Earnings Waterfall
Gensight Biologics SA

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

SIGHT Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one SIGHT stock?

The intrinsic value for Gensight Biologics SA (SIGHT) under the Base Case is 0.1998 EUR.

Is SIGHT stock undervalued or overvalued?

Compared with the current market price of 0.1204 EUR, the stock appears Undervalued by 40% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett